ویژگی‌های برجسته کتاب

• بررسی جامع هم‌زمانی بیماری‌های قلبی‌عروقی و دیابت.
• ارائه رویکردهای درمانی نوین و داروهای جدید در قلب‌شناسی و غدد.
• تمرکز بر داروهای کاهنده قند خون مؤثر بر خطر بیماری آترواسکلروتیک قلبی‌عروقی، نارسایی قلبی و پیشرفت بیماری کلیوی.
• تکیه بر درک جدید از پاتوفیزیولوژی و شواهد کارآزمایی‌های بالینی.
• ارائه محتوای بالینی فشرده و قابل استفاده در محل مراقبت.
• شامل نکات کاربردی بالینی و خلاصه‌های جمع‌بندی برای مرور سریع.
• دسترسی به نسخه الکترونیکی با قابلیت جست‌وجو، یادداشت‌گذاری، هایلایت و خوانش صوتی.

مخاطبان کتاب

این اثر برای متخصصان و پزشکان حوزه‌های قلب و عروق، غدد و مراقبت از بیماران مبتلا به دیابت و بیماری‌های قلبی‌عروقی طراحی شده است. محتوای آن برای پزشکان در سطوح مختلف تجربه کاربرد دارد.

About the Book

Part of the renowned Braunwald family of references, Diabeto-Cardiology, 2nd Edition, provides today’s clinicians with clear, authoritative guidance on the complex challenges of providing care to patients with cardiovascular and diabetes co-morbidities. Drs. Darren K. McGuire and Nikolaus Marx, along with a leading team of experts in cardiology and diabetes, address boththe foundational aspects and clinical implications for this growing number of patients, including recent breakthrough therapies and new medications that have contributed to newer and more effective treatments and improved patient outcomes. From cover to cover, this second edition offers reliable and current point-of-care coverage of the interwoven care needs of patients with these complex co-morbidities, making it an ideal resource for practitioners at all levels of experience.

Discusses cutting-edge therapeutic approaches to the medical care of cardiology patients with diabetes, combining coverage of the latest understanding of the complex relationship between diabetes and cardiovascular disease with recent clinical advances.

Offers a contemporary, clinical focus based on a new understanding of underlying pathologies, as well as application of evidence from clinical trials that have dramatically changed treatment and affected both cardiology and endocrinology practice.

Includes state-of-the-art coverage of antihyperglycemic medications that have demonstrated efficacy to reduce risk for atherosclerotic cardiovascular disease, heart failure, and kidney disease progression, that have affected a revolution of therapy in both cardiology and endocrinology.

Features a practical, concise presentation with a focus on actionable clinical content, including new Clinical Practice Points and Take Home Summaries.

An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.